LEE, J. C.; HUNG, J.-Y.; KIM, Y.-C.; CHANG, G.-C.; YOO, S.; YANG, S.-H.; DAVIS, K.; NAGAR, S.; TAYLOR, A.; LEE, S.; SHIH, J.-Y. Real-world Treatment Patterns in Patients with EGFR Mutation-positive NSCLC Receiving a First-Line, First- or Second-generation EGFR Tyrosine Kinase Inhibitor in South Korea and Taiwan. Asian Pacific Journal of Cancer Biology, v. 6, n. 2, p. 123-132, 20 maio 2021.